NanoInk, Inc., one of the world’s leading nanotechnology enterprises, announced today the launch of its NanoBioDiscovery Division. The new division will utilize Dip Pen Nanolithography(R) nanofabrication techniques, in combination with proprietary detection systems, to produce uniquely sensitive assays for protein discovery and identification. Femtofluidics handling of samples and reagents with these systems will help provide […]
Guildford, UK, December 11 2008 – IDBS is pleased to announce that the Australian pharmaceutical company, Cancer Therapeutics CRC (CTx, Melbourne, Australia), has selected both E-WorkBook and ActivityBase to manage its drug discovery and development on a global multi-site basis. CTx, one of the largest public / private partnerships of its type in the world, […]
SOUTH EASTON, Mass., Dec. 11 — Pressure BioSciences, Inc. (Nasdaq: PBIO – News; “PBI” or the “Company”) and Omni International (“Omni”) today announced that they have entered into a strategic marketing, distribution, and technology co-development Agreement. Under the terms of the Agreement, the companies will: (1) share market data, customer leads, technology assessments, and competitive […]
Lexington, MA December 11, 2008 – Protein Forest™, a leading developer of state-of-the-art sample fractionation technology and bioinformatics software for protein research, today announced that Children’s Hospital Boston has recently installed the digital ProteomeChip™ System (dPC™) to use in a recently NIH funded study entitled “Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) […]
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has been awarded a contract by the United States Department of Defense (DoD) to support the Food and Drug Administration’s (FDA) plans to access DoD healthcare data for rapid assessment of drug safety issues. […]
Teranode Corporation, the leading innovator of software for the Life Sciences industry, today announced the commercial release of its new Research Intelligence offering, Teranode Fuel. With a focus on tackling the problems that R&D teams are facing today as they seek to efficiently bring better drug candidates forward, Teranode Fuel delivers new insight to R&D […]
DNA2.0 opens DNA2.0 Ltd. in the United Kingdom and hires Michael Dyson to run European operations. Menlo Park, CA (PRWEB) December 10, 2008 — DNA2.0, the leading gene synthesis and protein engineering company, today announced the expansion of the company’s European operations with the creation of the United Kingdom-based DNA2.0 Ltd. Michael Dyson, PhD, has […]
Hoefer, Inc. has introduced a high quality DNA standard for use in fluorometry. The DQ302 Fluorometry Standard contains 0.25 ml DNA at a concentration of 1 ml/ml and is suitable for calibration of fluorometers, such as the Hoefer DQ300, when using the Hoescht 33258 (bis-benzimide) assay for quantitation of double stranded DNA. For complete information […]
Promega Corporation in conjunction with Kazusa DNA Research Institute (KDRI) in Chiba Prefecture, Japan will soon offer vectors encoding Promega HaloTag™ with genetic content from KDRI’s catalog. The KDRI content derives from large, typically difficult to clone human genes. In addition, there will be a comprehensive catalog of human transcription factors commonly used in research […]
Guava Technologies, Inc. has announced an exclusive partnership with IMV Technologies, world leader in reproductive biotechnology, to provide breeders and scientists with a unique cellular analysis platform that enables better evaluation of fertility parameters by introducing a new level of accuracy, reproducibility, productivity and cost effectiveness for livestock semen analysis. Performing a panel of simple […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
